## Abstract Occult hepatitis B virus (HBV) infection in patients with chronic hepatitis C has been found associated with severe liver damage, low response to interferon treatment and increased risk of developing HCC. However, doubts remain on its clinical impact and the sensitivity and specificity
Evolving clinical landscape of chronic hepatitis B: A multicenter Italian study
✍ Scribed by Tommaso Stroffolini; Piero L. Almasio; Evangelista Sagnelli; Alfonso Mele; Giovanni Battista Gaeta
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- English
- Weight
- 81 KB
- Volume
- 81
- Category
- Article
- ISSN
- 0146-6615
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
The aim of the study was to evaluate the characteristics of chronic hepatitis B with special reference to the geographical origin of the patients and to the prevalence of HBeAg and viral and non‐viral co‐factors of liver disease. A cross‐sectional multicenter survey was undertaken, which enrolled 1,386 HBsAg chronic carriers observed consecutively in 21 referral centers over a 6‐month period. The prevalence of HBeAg in patients was 11%; the presence of HBeAg was associated independently with a younger age and co‐infection with HIV. Anti‐HDV, anti‐HCV, or anti‐HIV antibodies were detected in 8.1%, 6.5%, and 2%, respectively. However, among the patients first diagnosed during the study period (incident cases), 14.3% were anti‐HDV positive. Seven percent of the patients were immigrants; they were younger than Italian patients and 18% were HBeAg positive; no difference was observed in the prevalence of anti‐HDV, anti‐HCV, or anti‐HIV antibodies. The presence of cirrhosis was associated independently with an age >52 years, the presence of anti‐HDV or anti‐HCV, alcohol use >4 drinks/day, and a high BMI. The clinical epidemiology of chronic hepatitis B virus (HBV) infection shows a dynamic profile, with the potential for re‐emergence of cases with HBeAg or anti‐HDV and an emerging impact of metabolic factors on the evolution of liver disease. J. Med. Virol. 81:1999–2006, 2009. © 2009 Wiley‐Liss, Inc.
📜 SIMILAR VOLUMES
## AND MASAO OMATA~ The effect of ursodeoxycholic acid on liver function tests and on bile acid metabolism was investigated in a multi-center randomized controlled dose study for chronic hepatitis C. Twenty, 18 and 19 patients were administered 150, 600 and 900 mglday, respectively of ursodeoxycho
This clinically relevant review focuses on recent findings concerning hepatitis B surface antigen (HBsAg) quantitation in untreated patients and treated patients with chronic hepatitis B. Recent studies and emerging data have shown that both HBsAg and hepatitis B virus (HBV) DNA levels decline durin
This clinically relevant review focuses on recent findings concerning hepatitis B surface antigen (HBsAg) quantitation in untreated patients and treated patients with chronic hepatitis B. Recent studies and emerging data have shown that both HBsAg and hepatitis B virus (HBV) DNA levels decline durin
In the June 2011 issue of HEPATOLOGY, in the article entitled ''Clinical utility of hepatitis B surface antigen quantitation in patients with chronic hepatitis B: A review'' (volume 53, pages 2121-2129) the data in Tables 2 and3 are to be corrected as listed below: On page 2124, under the heading '